Professor, Faculty of Medicine, University of Paris Descartes; Director, Apoptosis, Cancer and Immunity Research Team, French Medical Research Council (INSERM); Director, Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Center; Physician, Hôpital Européen George Pompidou, Paris, France; Foreign Adjunct Professor, Karolinska Institute, Stockholm, Sweden.
Dr. Kroemer received his Ph.D. and M.D. degrees from the University of Innsbruck, Austria in 1985, and completed his post-doctoral training at the Collège de France, Nogent-sur-Marne. He subsequently earned a Ph.D. in molecular biology from the Autonomous University of Madrid in 1992. Prior to joining INSERM in 1994, he was a senior scientist with the European Community at the Spanish National Research Council (CSIC), the National Center of Molecular Biology, and the National Center of Biotechnology.
Known for his groundbreaking work in the fields of cell biology and cancer research, Dr. Kroemer is credited with the discovery that the permeabilization of mitochondrial membranes constitutes a decisive step in programmed cell death. He has published more than 1,000 scholarly papers in top journals, including Science, Cell, and Nature.
In addition to his academic appointments, he is the current director of the Paris Alliance of Cancer Research Institutes (PACRI) and LabEx Immuno-Oncology; the founding director of the European Research Institute for Integrated Cellular Pathology (ERI-ICP); and the founding president of the European Academy of Tumor Immunology (EATI).
